Re-Engineering Drug Development II: Clinical Data Collection & Management
This article was originally published in Start Up
Executive Summary
Despite a history of failed products, start-up companies are looking to reinvent how data from clinical trials is collected and managed. Firms are trying to replace the point solutions of the past with broad software offerings that can take clients from "site to submission."